Effectiveness of a Structured Educational Program on Pain Intensity, Self-Efficacy, Foot Self-Care Behaviors, and Health-Related Quality of Life Among Adults With Diabetic Foot
DF-EDU-RCT
1 other identifier
interventional
400
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the effectiveness of a structured educational program on pain intensity, self-efficacy, foot self-care behaviors, and health-related quality of life among adults with diabetic foot. Diabetic foot complications are a major cause of morbidity, reduced quality of life, and disability among patients with diabetes mellitus. Poor self-care practices and inadequate knowledge contribute significantly to the progression of foot ulcers and related complications. Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive a structured educational program designed to improve knowledge, self-management skills, and adherence to recommended diabetic foot care practices. The control group will receive routine care provided by the healthcare facility. The educational program focuses on key areas including foot hygiene, daily foot inspection, appropriate footwear, glycemic control, and early identification of warning signs of complications. The primary outcomes of the study include changes in pain intensity, self-efficacy, foot self-care behaviors, and health-related quality of life, which will be assessed at baseline and after the intervention period. The findings of this study are expected to contribute to improving nursing educational interventions and enhancing self-management outcomes among patients with diabetic foot.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
May 4, 2026
April 1, 2026
29 days
April 24, 2026
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity Measured Using the Numeric Rating Scale (NRS)
Change in pain intensity measured using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain intensity.
Baseline and post-intervention (4-8 weeks).
Secondary Outcomes (1)
Diabetes Self-Efficacy Measured Using the Diabetes Self-Efficacy Scale (DSES)
Baseline and post-intervention (4-8 weeks).
Other Outcomes (2)
Foot Self-Care Behaviors Measured Using the Diabetic Foot Self-Care Questionnaire (DFSQ-UMA-En)
Baseline and post-intervention (4-8 weeks).
Health-Related Quality of Life Measured Using the EQ-5D-5L Questionnaire
Baseline and post-intervention (4-8 weeks).
Study Arms (2)
Educational Program Group
EXPERIMENTALControl Group
ACTIVE COMPARATORInterventions
A structured educational program designed for adults with diabetic foot to improve self-care practices and disease management. The program includes planned teaching sessions delivered by trained nursing staff and covers key topics such as foot hygiene, daily foot inspection, proper nail and skin care, appropriate footwear selection, glycemic control, and early identification of complications. Educational strategies include lectures, demonstrations, printed materials, and interactive discussions to enhance participants' knowledge, self-efficacy, and adherence to recommended foot care behaviors.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years and older
- Diagnosed with diabetic foot
- Able to communicate effectively
- Willing to participate in the educational program
- Able to provide written informed consent
You may not qualify if:
- Patients with severe or unstable medical conditions (e.g., advanced heart failure, renal failure, or active infections) that may interfere with participation
- Patients with major lower-limb amputation or severe foot deformities preventing participation in the educational program or assessments
- Patients with cognitive impairments, psychiatric disorders, or communication difficulties affecting understanding or compliance
- Pregnant or lactating women
- Patients who refuse to provide informed consent or withdraw at any stage of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ministry of Health Primary Healthcare Centers
Jerash, Dours, 009627, Jordan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jawad AHMAD Ahmed, Asst.Prof.Dr
Jerash University, Faculty of Nursing
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking will be applied. Participants and investigators will be aware of group assignments due to the nature of the educational intervention.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Department of Nursing
Study Record Dates
First Submitted
April 24, 2026
First Posted
May 4, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
May 30, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared publicly. The data collected in this study contain sensitive health information related to patients with diabetic foot and will be used exclusively for research purposes within the approved study protocol. To ensure participant confidentiality and comply with ethical and institutional review board requirements, access to the dataset will be restricted to the principal investigator and authorized research team members only. Aggregate results may be published in peer-reviewed journals, but individual-level data will not be made available to other researchers.